Ledger.Open graph →
SEC Form D · filed May 3, 2017

CeleCor Therapeutics, Inc

Offering
$25.0M
Sold
—
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Robert S. Hillman · San Diego, CAExec · DirectorPeter B. Finn · Boston, MAExecAndreas S. Ritzi · San Diego, CADirectorPeter B. Finn · Boston, MAExec · DirectorHongfei Zhang · New York, NYExecCaspar F. Sturm · San Diego, CADirectorPaul V. Vacheron · Los Angeles, CAExecSusan Webb · New York, NYExec · DirectorAndreas S. Ritzi · San Diego, CADirectorCaspar F. Sturm · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗